ClinicalTrials.Veeva

Menu
S

Salisbury VA Medical Center | Salisbury, NC

Research site
(Unclaimed)

Site insights

Top conditions

Top treatments

Mevrometostat
PF-06821497
Abiraterone Acetate
Atorvastatin

Curious how this site stacks up to its peers?

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Active trials

3 of 4 total trials

A Study to Learn About the Investigational Medicine Called PF-06821497 (Mevrometostat) in Men With mCRPC Who Were Previously Treated With Abiraterone Acetate for Prostate Cancer (MEVPRO-1).

Pfizer MEVPRO-1 (C2321014) is a randomized, open-label, multi-center clinical trial evaluating whether combining the study medicine (PF-06821497) wit...

Enrolling
Metastatic Castrate Resistant Prostate Cancer (mCRPC)
Drug: PF-06821497
Drug: Enzalutamide

This study will explore whether a combination of the investigational drug PF-06821497 and enzalutamide will work better than taking enzalutamide alon...

Enrolling
Metastatic Castration-Resistant Prostate Cancer
Drug: PF-06821497
Drug: Placebo

The study objective is to evaluate the safety of the iTind device comparied to UroLift.

Enrolling
Benign Prostatic Hyperplasia (BPH)
Procedure: UroLift
Device: iTind

Trial sponsors

Pfizer logo
Duke University logo
O

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems